BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 20718866)

  • 1. Catalytic digestion of human tumor necrosis factor-α by antibody heavy chain.
    Hifumi E; Higashi K; Uda T
    FEBS J; 2010 Sep; 277(18):3823-32. PubMed ID: 20718866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel domain antibody rationally designed against TNF-alpha using variable region of human heavy chain antibody as scaffolds to display antagonistic peptides.
    Qin W; Feng J; Li Y; Lin Z; Shen B
    Mol Immunol; 2007 Mar; 44(9):2355-61. PubMed ID: 17125837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular analysis of multicatalytic monoclonal antibodies.
    Zein HS; da Silva JA; Miyatake K
    Mol Immunol; 2010 May; 47(9):1747-56. PubMed ID: 20356628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Catalytic features of monoclonal antibody i41SL1-2 subunits.
    Hifumi E; Kondo H; Mitsuda Y; Uda T
    Biotechnol Bioeng; 2003 Nov; 84(4):485-93. PubMed ID: 14574707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel human scFv fragment against TNF-alpha from de novo design method.
    Chang H; Qin W; Li Y; Zhang J; Lin Z; Lv M; Sun Y; Feng J; Shen B
    Mol Immunol; 2007 Jul; 44(15):3789-96. PubMed ID: 17485112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A catalytic antibody heavy chain HpU-2 degrading its epitope peptide and H. pylori urease.
    Hifumi E; Yamada Y; Uda T
    Immunol Lett; 2006 Feb; 103(1):68-74. PubMed ID: 16321448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Catalytic antibody light chain capable of cleaving a chemokine receptor CCR-5 peptide with a high reaction rate constant.
    Mitsuda Y; Hifumi E; Tsuruhata K; Fujinami H; Yamamoto N; Uda T
    Biotechnol Bioeng; 2004 Apr; 86(2):217-25. PubMed ID: 15052642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-reactive binding of cyclic peptides to an anti-TGFalpha antibody Fab fragment: an X-ray structural and thermodynamic analysis.
    Hahn M; Winkler D; Welfle K; Misselwitz R; Welfle H; Wessner H; Zahn G; Scholz C; Seifert M; Harkins R; Schneider-Mergener J; Höhne W
    J Mol Biol; 2001 Nov; 314(2):293-309. PubMed ID: 11718562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific degradation of H. pylori urease by a catalytic antibody light chain.
    Hifumi E; Hatiuchi K; Okuda T; Nishizono A; Okamura Y; Uda T
    FEBS J; 2005 Sep; 272(17):4497-505. PubMed ID: 16128818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cleavage specificity of a proteolytic antibody light chain and effects of the heavy chain variable domain.
    Sun M; Gao QS; Kirnarskiy L; Rees A; Paul S
    J Mol Biol; 1997 Aug; 271(3):374-85. PubMed ID: 9268666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA (A*0201) mimicry by anti-idiotypic monoclonal antibodies.
    Burlingham WJ; Jankowska-Gan E; DeVito-Haynes L; Fechner JH; Hogan KT; Claas FH; Mulder A; Wang X; Ferrone S
    J Immunol; 1998 Dec; 161(12):6705-14. PubMed ID: 9862700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of hapten binding and catalytic determinants in a family of catalytic antibodies.
    Ulrich HD; Schultz PG
    J Mol Biol; 1998 Jan; 275(1):95-111. PubMed ID: 9451442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rational design of potent mimic peptide derived from monoclonal antibody: antibody mimic design.
    Feng J; Li Y; Zhang W; Shen B
    Immunol Lett; 2005 May; 98(2):311-6. PubMed ID: 15860233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Affinity maturation of a high-affinity human monoclonal antibody against the third hypervariable loop of human immunodeficiency virus: use of phage display to improve affinity and broaden strain reactivity.
    Thompson J; Pope T; Tung JS; Chan C; Hollis G; Mark G; Johnson KS
    J Mol Biol; 1996 Feb; 256(1):77-88. PubMed ID: 8609615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production and characterization of a bacterial single-chain antibody fragment specific to B-cell-activating factor of the TNF family.
    Cao P; Tang XM; Guan ZB; Diao ZY; Zhang SQ
    Protein Expr Purif; 2005 Oct; 43(2):157-64. PubMed ID: 16023370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gangliosides, Ab1 and Ab2 antibodies II. Light versus heavy chain: An idiotype-anti-idiotype case study.
    López-Requena A; Rodríguez M; de Acosta CM; Moreno E; Puchades Y; González M; Talavera A; Valle A; Hernández T; Vázquez AM; Pérez R
    Mol Immunol; 2007 Feb; 44(5):1015-28. PubMed ID: 16620986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endopeptidase character of monoclonal antibody i41-7 subunits.
    Hatiuchi K; Hifumi E; Mitsuda Y; Uda T
    Immunol Lett; 2003 May; 86(3):249-57. PubMed ID: 12706527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Humanization of an anti-human TNF-alpha antibody by variable region resurfacing with the aid of molecular modeling.
    Zhang W; Feng J; Li Y; Guo N; Shen B
    Mol Immunol; 2005 Aug; 42(12):1445-51. PubMed ID: 15950738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The critical role of arginine residues in the binding of human monoclonal antibodies to cardiolipin.
    Giles I; Lambrianides N; Latchman D; Chen P; Chukwuocha R; Isenberg D; Rahman A
    Arthritis Res Ther; 2005; 7(1):R47-56. PubMed ID: 15642142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phage-displayed antibody libraries of synthetic heavy chain complementarity determining regions.
    Sidhu SS; Li B; Chen Y; Fellouse FA; Eigenbrot C; Fuh G
    J Mol Biol; 2004 Apr; 338(2):299-310. PubMed ID: 15066433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.